openPR Logo
Press release

Epigenetics Market Size, Share & Trends [2028] | Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US)

05-28-2024 08:45 AM CET | Health & Medicine

Press release from: MarketsandMarkets

Epigenetics Market

Epigenetics Market

Epigenetics Market in terms of revenue was estimated to be worth $1.8 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 18.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The growth of the market is projected to be driven by factors such as rising investment in R&D, declining sequencing cost & time, favourable government initiatives & funding for epigenetics research, advancement in technology for epigenetic research and increasing demand for epigenetic-based therapeutics.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896&utm_source=Openpe&utm_campaign=paid&utm_content=Referral

The kits & reagents segment is expected to have the dominant share of the epigenetics market in 2022.

Based on technology, the global epigenetics market is segmented into kits & reagents, enzymes, instruments and accessories, software, and service. The kits & reagents is further segmented into antibodies, chip-sequencing kits & reagents, whole-genome amplification kits & reagents and 5-HMC & 5-MC Analysis kits & reagents, histones and other kits & reagents. In 2022, the Antibodies segment held the largest share of the epigenetics market. The rising adoption of antibodies in detection, identification, and alteration/modification of proteins followed by their role in monitoring cell regulation & expression are the driving factor for the growth of the antibodies segment during the forecast period.

The DNA methylation segment accounted for the largest share of the method segment in the epigenetics market in 2022.

Based on disease indication, the epigenetics market is segmented DNA methylation, histone modifications, and other methods (non-coding RNA and chromatin remodelling). The DNA methylation segment is anticipated to grow at significant CAGR during the forecast period owing to factor such as efficacy of the DNA methylation technique in oncology studies.

The Asia Pacific region is the fastest-growing region of the epigenetics market in 2022.

The Asia Pacific is accounted to be the fastest-growing segment of the market. The growth of the epigenetics markets in the region is driven by the expanding international presence of domestic players by adopting strategic agreements, partnerships, and collaborations and Improving healthcare infrastructure in developing Asia Pacific economies.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=896&utm_source=Openpr&utm_campaign=paid&utm_content=Referral

Epigenetics Market Dynamics:

Drivers:

1. Growing investments in research & development

2. Declining sequencing costs & time

3. Favorable government initiatives and funding for epigenetics research

4. Technological advancements in epigenetics research

5. Rising demand for epigenetic-based therapeutics

Restraints:

1. Limited applications of epigenomic data in toxicology

2. Data privacy concerns and security issues

Opportunities:

1. Expanding applications of epigenetics

2. Integration of artificial intelligence and machine learning algorithms

Challenge:

1. Concerns regarding quality of antibodies

2. Challenges associated with epigenetic editing

Key Market Players of Epigenetics Industry:

The epigenetics market is moderately consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US), Bio-Rad Laboratories Inc. (US), Promega Corporation (US), Revvity (US), Qiagen (Germany), New England Biolabs (US), Zymo Research Corporation (US), Diagenode SA (US), F. Hoffmann-La Roche Ltd (Switzerland) and Epigentek Group Inc. (US) are some of the leading players in this market. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, and agreements, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 60%, and Demand Side - 40%
By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
By Region: North America: 40%, Europe: 27%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 3%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=896&utm_source=Openpr&utm_campaign=paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
1.80 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/epigenetics-technologies-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/epigenetics-technologies.asp

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epigenetics Market Size, Share & Trends [2028] | Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US) here

News-ID: 3514614 • Views:

More Releases from MarketsandMarkets

Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your Revenue
Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your R …
The global laser interferometer market is expected to be valued at 315 million in 2024 and is projected to reach USD 447 million by 2029, at a CAGR of 7.2% from 2024 to 2029. Emerging applications in industries push the market's growth due to the growing demand for precision in the manufacturing sector. However, challenges such as higher initial investments and maintenance costs cause problems. Despite these, opportunities arise for
With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to Surpass USD 36.7 billion
With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to …
The battery testing, inspection, and certification market is projected to reach USD 36.7 billion by 2029 from USD 14.9 billion in 2024 at a CAGR of 19.6% during the forecast period. Increasing adoption of EVs and energy storage systems, rising enforcement of stringent standards to ensure battery safety, thriving portable electronics industry, and rapid advances in battery technology are the major factors contributing to the market growth. Download PDF Brochure @
Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMarkets
Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMar …
The global RTLS market for healthcare is projected to grow from USD 2.3 billion in 2024 to USD 5.7 billion by 2029, at a compound annual growth rate of 19.6% from 2024 to 2029. As it attracts more and more players who enter this market with innovative RTLS features for customers, the market for RTLS technology is rapidly increasing. Top companies in this market focus on healthcare, retail, and manufacturing
Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2030 | Leading key players are ABB, Schneider Electric, Eaton, Vertiv
Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2 …
According to a research report "Offsite Data Center Power Infrastructure Market by Component (Solutions and Services), Vertical (BFSI, Media & Entertainment, Government & Defence, Healthcare, Manufacturing, IT & Telecom, Retail) and Region - Global Forecast to 2030" published by MarketsandMarkets, the market size for global offsite data center power infrastructure market is projected to reach approximately USD 35.4 billion by the year 2030, as compared to the estimated value of

All 5 Releases


More Releases for Epigenetics

Epigenetics: Critical Driver Shaping the Rising Cancer Prevalence And Other Dise …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Epigenetics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for epigenetics has seen a significant expansion in the last few years. The market is projected to escalate from $10.65 billion in 2024 to $12.83 billion in 2025, displaying a compound annual growth rate (CAGR) of 20.4%. The
Epigenetics Market Trends and Research Developments
On March 25, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Epigenetics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many
Complete PDF Guide to Epigenetics
A single or multiple changes in phenotype without changing the genotype which affects the cells. The changes occurred due to epigenetics are regular and natural and can also be influenced by several factors such as age, environment, lifestyle, and conditions of diseases. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPHE100000971/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Epigenetics Market are: • Merck KgaA • Thermo Fisher Scientific Inc • Abcam Plc • Agilent Technologies Inc • Qiagen • Bio-Rad Laboratories Inc • Active Motif • Perkin Elmer Inc • New
Epigenetics Market worth $4.3 billion by 2028
Browse 367 market data Tables and 45 Figures spread through 366 Pages and in-depth TOC on "Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology) - Global Forecast to 2028 Epigenetics Market [https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html?utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $1.8 billion in 2023 and is poised to reach $4.3 billion by
Epigenetics Analysis: The Roadmap to Precision Oncology
[City, Date] - In the dynamic landscape of modern medicine, precision oncology has emerged as a transformative force, leveraging genomic data to provide patient-specific cancer treatments. This groundbreaking field, now seamlessly integrated into mainstream clinical practices, relies on epigenetic analysis to unravel the molecular intricacies of cancer cells and identify targetable alterations, commonly known as biomarkers. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5628 Epigenetic analysis, enabling the rapid and reliable sequencing of multiple
Epigenetics Diagnostic Market Industry Analysis - Epigenetics Diagnostic Market …
The most recent study offered by Acumen Research and Consulting focuses Epigenetics Diagnostic Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Epigenetics Diagnostic Market trends in order to assess its current and future potential. Our Epigenetics Diagnostic Market analysis also provides market participants and new entrants with a comprehensive